Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluticasone propionate/salmeterol versus fluticasone propionate in adolescents and adults with asthma
2011-001644-29Phase 4Completed
- Sponsor
- GSK
- Start
- Dec 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of fluticasone propionate and salmeterol in asthma (2 arms), sponsored by GSK. Primary endpoints: Serious asthma-related events and Composite serious asthma-related event risk. Started Dec 2011; status: completed.
02
Drugs
fluticasone propionatesalmeterol
03
Conditions
asthma
Beyond the preview
Go deeper on 2011-001644-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-001644-29.